What if the FDA quietly clarified the rules for migraine brain-stimulators?
Case Review:
28-year-old female, presents for worsening intermittent throbbing unilateral headache with visual aura x3 months; attacks last 6–8 hours, 4–6 migraine days/month despite ibuprofen and occasional sumatriptan. Vitals: BP 118/76 mm Hg, HR 72. Neuro exam normal. Meds: sumatriptan PRN, ibuprofen PRN. Pertinent negative: no history of seizures or implanted metallic devices.
Question:
Which is the most appropriate next step for acute management of her typical migraine with aura?
A. Start daily topiramate for prevention
B. Refer for occipital nerve block
C. Offer single‑pulse transcranial magnetic stimulation for acute treatment of migraine with aura CORRECT
D. Begin high‑dose opioid for refractory pain control
E. Immediately start CGRP monoclonal antibody therapy
Description:
Single‑pulse transcranial magnetic stimulation (sTMS) can interrupt the brain wave pattern called cortical spreading depression that underlies migraine aura and early pain signaling; by briefly changing cortical excitability at attack onset, sTMS can reduce pain and shorten attack duration for patients with aura, explaining benefit in trials and making it an appropriate acute option for this patient. Test your understanding of this mechanism with practicetest.
Clinical Insight:
This pattern (aura with early attack) is where sTMS has the clearest trial support; rTMS (repetitive trains) is studied for prevention but evidence and protocols vary. Always screen for seizure history and metallic implants before considering TMS; when chosen, integrate with acute meds and follow safety guidance. Review the key practical checks and indications with studysheet.
Why this matters:
Migraine with aura affects many young adults and selecting a non-drug acute option helps when medications are ineffective or contraindicated. Exams often test device indications and safety screening.
Quick take-away:
Recognize migraine with aura and early presentation.
Screen for seizure risk and implants before TMS.
Consider single‑pulse TMS as an acute option when indicated and available.
Common pitfalls to watch for:
Offering TMS without checking seizure history or metallic implants.
Assuming all TMS protocols are interchangeable.
Using opioids for routine migraine attacks.
Try targeted flashcards to memorize indications, contraindications, and device safety checks for TMS.
Comments